Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Rivaroxaban Meets Primary Endpoint in ATLAS ACS TIMI 51
Rivaroxaban Meets Primary Endpoint in ATLAS ACS TIMI 51
Rivaroxaban Meets Primary Endpoint in ATLAS ACS TIMI 51
Submitted by
admin
on September 30, 2011 - 9:26am
Source:
Forbes
News Tags:
rivaroxaban
JNJ
Xarelto
acute coronary syndrome
Bayer
Headline:
Rivaroxaban Meets Primary Endpoint in ATLAS ACS TIMI 51
Do Not Allow Advertisers to Use My Personal information
